Related references
Note: Only part of the references are listed.Can amphotericin B and itraconazole be co-delivered orally? Tailoring oral fixed-dose combination coated granules for systemic mycoses
Raquel Fernandez-Garcia et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2023)
The Role of Cyclodextrins in COVID-19 Therapy-A Literature Review
Beatriz Almeida et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
When Interactions Between Bile Salts and Cyclodextrin Cause a Negative Food Effect: Dynamic Dissolution/Permeation Studies with Itraconazole (Sporanox®) and Biomimetic Media
Arianna Cuoco et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2023)
On the Physical Stability of Leucine-Containing Spray-Dried Powders for Respiratory Drug Delivery
Mani Ordoubadi et al.
PHARMACEUTICS (2023)
Targeting lung macrophages for fungal and parasitic pulmonary infections with innovative amphotericin B dry powder inhalers
E. de Pablo et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2023)
Cepharanthine Dry Powder Inhaler for the Treatment of Acute Lung Injury
Di Liang et al.
MOLECULES (2023)
Effect of Amphotericin B on the Thermodynamic Properties and Surface Morphology of the Pulmonary Surfactant Model Monolayer during Respiration
Juan Wang et al.
MOLECULES (2023)
Amphotericin B-Silver Hybrid Nanoparticles Help to Unveil the Mechanism of Biological Activity of the Antibiotic: Disintegration of Cell Membranes
Sebastian Janik et al.
MOLECULES (2023)
Identifying genetic variants associated with amphotericin B (AMB) resistance in Aspergillus fumigatus via k-mer-based GWAS
Meng-Meng Chen et al.
FRONTIERS IN GENETICS (2023)
Invasive pulmonary aspergillosis real-world outcomes: Clinical features and risk factors associated with increased mortality
Andres F. Henao-Martinez et al.
MEDICAL MYCOLOGY (2023)
Optimization and Characterization of Sodium Alginate Beads Providing Extended Release for Antidiabetic Drugs
Bence Sipos et al.
MOLECULES (2023)
Susceptibility patterns of amphotericin B, itraconazole, posaconazole, voriconazole and caspofungin for isolates causing invasive mould infections from the SENTRY Antifungal Surveillance Program (2018-2021) and application of single-site epidemiological cutoff values to evaluate amphotericin B activity
Michael A. Pfaller et al.
MYCOSES (2023)
The Development of a Novel Pharmaceutical Formulation of D-Tagatose for Spray-Drying
Heather R. Campbell et al.
JOURNAL OF PHARMACEUTICAL INNOVATION (2022)
Self-assembling, supramolecular chemistry and pharmacology of amphotericin B: Poly-aggregates, oligomers and monomers
Raquel Fernandez-Garcia et al.
JOURNAL OF CONTROLLED RELEASE (2022)
Pulmonary delivery of resveratrol-β-cyclodextrin inclusion complexes for the prevention of zinc chloride smoke-induced acute lung injury
Wanmei Wang et al.
DRUG DELIVERY (2022)
Co-spray-dried poly-L-lysine with L-leucine as dry powder inhalations for the treatment of pulmonary infection: Moisture-resistance and desirable aerosolization performance
Xuejuan Zhang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2022)
Indications that the Antimycotic Drug Amphotericin B Enhances the Impact of Platelets on Aspergillus
Gunter Rambach et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)
Trends in the Prevalence of Amphotericin B-Resistance (AmBR) among Clinical Isolates of Aspergillus Species
Hamed Fakhim et al.
JOURNAL DE MYCOLOGIE MEDICALE (2022)
Optimization of Lipid Extraction from Spirulina spp. by Ultrasound Application and Mechanical Stirring Using the Taguchi Method of Experimental Design
Emilia Neag et al.
MOLECULES (2022)
COVID-19-associated invasive pulmonary aspergillosis: high incidence or difficult diagnosis?
Anahita Rouze et al.
INTENSIVE CARE MEDICINE (2021)
New In Vitro-In Silico Approach for the Prediction of In Vivo Performance of Drug Combinations
Cristiana Correia et al.
MOLECULES (2021)
Spray-dried lactose-leucine microparticles for pulmonary delivery of antimycobacterial nanopharmaceuticals
Durairaj Thiyagarajan et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2021)
Incidence of invasive pulmonary aspergillosis among critically ill COVID-19 patients
Frederic Lamoth et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Oral Fixed-Dose Combination Pharmaceutical Products: Industrial Manufacturing Versus Personalized 3D Printing
Raquel Fernandez-Garcia et al.
PHARMACEUTICAL RESEARCH (2020)
Scale-up of pharmaceutical spray drying using scale-up rules: A review
Sadegh Poozesh et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Fungi-Induced Upper and Lower Respiratory Tract Allergic Diseases: One Entity
Aleksandra Barac et al.
FRONTIERS IN MICROBIOLOGY (2018)
Co-Spray Dried Mannitol/Poly(amidoamine)-Doxorubicin Dry-Powder Inhaler Formulations for Lung Adenocarcinoma: Morphology, In Vitro Evaluation, and Aerodynamic Performance
Qian Zhong
AAPS PHARMSCITECH (2018)
Enhanced pulmonary absorption of poorly soluble itraconazole by micronized cocrystal dry powder formulations
Masatoshi Karashima et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2017)
Unmet clinical needs in the treatment of systemic fungal infections: The role of amphotericin B and drug targeting
Raquel Fernandez-Garcia et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Aggregated Nanotransfersomal Dry Powder Inhalation of Itraconazole for Pulmonary Drug Delivery
Mehdi Hassanpour Aghdam et al.
ADVANCED PHARMACEUTICAL BULLETIN (2016)
Updates on Aspergillus, Pneumocystis and other opportunistic pulmonary mycoses
Jose Curbelo et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2015)
Alginate coated chitosan microparticles mediated oral delivery of diphtheria toxoid. Part A: Systematic optimization, development and characterization
Anshuman Shukla et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
Fixed-dose combination products and unintended drug interactions: urgent need for pharmacogenetic evaluation
Jorge Duconge et al.
PHARMACOGENOMICS (2015)
Updates on Aspergillus, Pneumocystis and other opportunistic pulmonary mycoses
Jose Curbelo et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2015)
New amphotericin B-gamma cyclodextrin formulation for topical use with synergistic activity against diverse fungal species and Leishmania spp.
Helga K. Ruiz et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2014)
Amphotericin B- and Voriconazole-Echinocandin Combinations against Aspergillus spp.: Effect of Serum on Inhibitory and Fungicidal Interactions
Antigoni Elefanti et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols
Chun-Woong Park et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Spray Drying of Mannitol as a Drug Carrier-The Impact of Process Parameters on Product Properties
Eva Maria Littringer et al.
DRYING TECHNOLOGY (2012)
Leucine enhances aerosol performance of Naringin dry powder and its activity on cystic fibrosis airway epithelial cells
Lucia Prota et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
Optimization of bioassay method for the quantitative microbiological determination of amphotericin B
Andras Fittler et al.
MYCOSES (2010)
Scaling up the spray drying process from pilot to production scale using an atomized droplet size criterion
Pia Thybo et al.
PHARMACEUTICAL RESEARCH (2008)
Evaluation of the Neo-Sensitabs® diffusion method for determining the antifungal susceptibilities of Cryptococcus gattii isolates, using three different agar media
Isabel Pujol et al.
REVISTA IBEROAMERICANA DE MICOLOGIA (2008)
Amphotericin B: Is a lipid-formulation gold standard feasible?
B Spellberg et al.
CLINICAL INFECTIOUS DISEASES (2004)